Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabelle Vilgrain

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
International Journal of Molecular Sciences|February 25, 2023
Dialogue between VE-Cadherin and Sphingosine 1 Phosphate Receptor1 (S1PR1) for Protecting Endothelial FunctionsOlivia Garnier, Isabelle Vilgrain
The Journal of Allergy and Clinical Immunology|May 31, 2014
VE-cadherin, a potential marker for endothelial cell activation during hereditary angioedema attacksLaurence Bouillet, Isabelle Vilgrain
European Journal of Cancer (Oxford, England : 1990)|June 18, 2022
Letter re: Integration of deep learning-based image analysis and genomic data in cancer pathology: A systematic review: Label-free diagnostic technique to differentiate cancer cells from healthy cellsIsabelle Vilgrain, Donald K Martin
Trends in Cardiovascular Medicine|February 14, 2006
Angiogenesis: the VE-cadherin switchYann Wallez, Isabelle Vilgrain, Philippe Huber
Vascular Medicine (London, England)|July 2, 2015
Soluble vascular endothelial-cadherin and auto-antibodies to human vascular endothelial-cadherin in human diseases: Two new biomarkers of endothelial dysfunctionSophie Blaise, Helena Polena, Isabelle Vilgrain
Endocrinology|September 10, 2003
Expressional regulation of the angiopoietin-1 and -2 and the endothelial-specific receptor tyrosine kinase Tie2 in adrenal atrophy: a study of adrenocorticotropin-induced repairOlivier Féraud, Christine Mallet, Isabelle Vilgrain
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 26, 2005
Platelet-activating factor increases VE-cadherin tyrosine phosphorylation in mouse endothelial cells and its association with the PtdIns3'-kinaseHélène Hudry-Clergeon, Dominique Stengel, Ewa Ninio, et al.
Anticancer Research|October 3, 2022
Microtumor Spheroids Provide a Model for Studying Molecules Involved in Vascular Organization: An Illustrative Study for VE-cadherinPaul Dembélé, Olivia Garnier, Donald K Martin, et al.
The European Respiratory Journal|October 29, 2021
Reply: Soluble VE-cadherin: not just a marker of endothelial permeabilityOlfa Harki, Gilles Faury, Isabelle Vilgrain, et al.
European Journal of Dermatology : EJD|April 24, 2015
Towards a specific marker for acute bradykinin-mediated angioedema attacks: a literature reviewAlban Deroux, Isabelle Vilgrain, Chantal Dumestre-Pérard, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
International Journal of Molecular Sciences|February 25, 2023
Dialogue between VE-Cadherin and Sphingosine 1 Phosphate Receptor1 (S1PR1) for Protecting Endothelial FunctionsOlivia Garnier, Isabelle Vilgrain
The Journal of Allergy and Clinical Immunology|May 31, 2014
VE-cadherin, a potential marker for endothelial cell activation during hereditary angioedema attacksLaurence Bouillet, Isabelle Vilgrain
European Journal of Cancer (Oxford, England : 1990)|June 18, 2022
Letter re: Integration of deep learning-based image analysis and genomic data in cancer pathology: A systematic review: Label-free diagnostic technique to differentiate cancer cells from healthy cellsIsabelle Vilgrain, Donald K Martin
Trends in Cardiovascular Medicine|February 14, 2006
Angiogenesis: the VE-cadherin switchYann Wallez, Isabelle Vilgrain, Philippe Huber
Vascular Medicine (London, England)|July 2, 2015
Soluble vascular endothelial-cadherin and auto-antibodies to human vascular endothelial-cadherin in human diseases: Two new biomarkers of endothelial dysfunctionSophie Blaise, Helena Polena, Isabelle Vilgrain
Endocrinology|September 10, 2003
Expressional regulation of the angiopoietin-1 and -2 and the endothelial-specific receptor tyrosine kinase Tie2 in adrenal atrophy: a study of adrenocorticotropin-induced repairOlivier Féraud, Christine Mallet, Isabelle Vilgrain
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 26, 2005
Platelet-activating factor increases VE-cadherin tyrosine phosphorylation in mouse endothelial cells and its association with the PtdIns3'-kinaseHélène Hudry-Clergeon, Dominique Stengel, Ewa Ninio, et al.
Anticancer Research|October 3, 2022
Microtumor Spheroids Provide a Model for Studying Molecules Involved in Vascular Organization: An Illustrative Study for VE-cadherinPaul Dembélé, Olivia Garnier, Donald K Martin, et al.
The European Respiratory Journal|October 29, 2021
Reply: Soluble VE-cadherin: not just a marker of endothelial permeabilityOlfa Harki, Gilles Faury, Isabelle Vilgrain, et al.
European Journal of Dermatology : EJD|April 24, 2015
Towards a specific marker for acute bradykinin-mediated angioedema attacks: a literature reviewAlban Deroux, Isabelle Vilgrain, Chantal Dumestre-Pérard, et al.
Pageof 4